Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 Oct 2024
18 Oct 2024
Historique:
received:
01
04
2024
accepted:
30
09
2024
medline:
19
10
2024
pubmed:
19
10
2024
entrez:
18
10
2024
Statut:
epublish
Résumé
This meta-analysis investigates the effect of classic psychedelic drugs on empathy and focuses on cognitive and emotional empathy measured using the Multifaceted Empathy Test (MET). Empathy entails the ability to understand and share the feelings of another and is a significant component of social interaction. Several studies have examined the effects of psychedelic drugs such as LSD, psilocybin and ayahuasca on empathy, yet their overall effect has not been studied so far. In this meta-analysis, we reviewed data from studies up to November 2023 with the aim of examining the effects of various psychedelic drugs on empathic abilities broadly. Our findings suggest that classical psychedelics significantly enhance explicit and implicit emotional empathy without affecting measures of cognitive empathy. The results emphasize the need to continue testing the therapeutic potential of classic psychedelic drugs.
Identifiants
pubmed: 39424835
doi: 10.1038/s41598-024-74810-w
pii: 10.1038/s41598-024-74810-w
doi:
Substances chimiques
Hallucinogens
0
Psilocybin
2RV7212BP0
Lysergic Acid Diethylamide
8NA5SWF92O
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
24480Informations de copyright
© 2024. The Author(s).
Références
de Vignemont, F. & Singer, T. The empathic brain: how, when and why? Trends Cogn. Sci. 10(10), 435–441. https://doi.org/10.1016/j.tics.2006.08.008 (2006).
doi: 10.1016/j.tics.2006.08.008
pubmed: 16949331
Quesque, F. & Rossetti, Y. What do theory-of-mind tasks actually measure? Theory and practice. Perspect. Psychol. Sci. 15(2), 384–396. https://doi.org/10.1177/1745691619896607 (2020).
doi: 10.1177/1745691619896607
pubmed: 32069168
VandenBos, G. R. (ed) APA Dictionary of Psychology (American Psychological Association, 2007).
Shamay-Tsoory, S. G. The neural bases for Empathy. Neuroscientist. 17(1), 18–24. https://doi.org/10.1177/1073858410379268 (2011).
doi: 10.1177/1073858410379268
pubmed: 21071616
Goodhew, S. C. & Edwards, M. The relationship between cognitive failures and empathy. Pers. Indiv. Differ. 186, 111384. https://doi.org/10.1016/j.paid.2021.111384 (2022).
doi: 10.1016/j.paid.2021.111384
Uzefovsky, F. & Knafo-Noam, A. Empathy develops throughout the life span. In Social cognition (89–115). Routledge. (2016).
Zaki, J. & Ochsner, K. N. The neuroscience of empathy: Progress, pitfalls and promise. Nat. Neurosci. 15(5), 675–680 (2012).
doi: 10.1038/nn.3085
pubmed: 22504346
Quesque, F. et al. Defining key concepts for mental state attribution. Nat. Revi. Psychol. https://doi.org/10.1038/s44271-024-00077-6 (2024).
doi: 10.1038/s44271-024-00077-6
Braunstein, L. M., Gross, J. J. & Ochsner, K. N. Explicit and implicit emotion regulation: A multi-level framework. Soc. Cognit. Affect. Neurosci. 12(10), 1545–1557 (2017).
doi: 10.1093/scan/nsx096
Greenberg, L. S., Elliott, R., Watson, J. C. & Bohart, A. C. Empathy. Psychother. Theory Res. Pract. Train. 38(4), 380–384. https://doi.org/10.1037/0033-3204.38.4.380 (2001).
doi: 10.1037/0033-3204.38.4.380
Uthaug, M. V. et al. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats. Psychopharmacology, 238(7), 1899–1910. (2021). https://doi.org/10.1007/s00213-021-05817-8
Kiraga, M. K. et al. Persisting effects of ayahuasca on empathy, creative thinking, decentering, personality, and well-being. Front. Pharmacol. 12, 721537. https://doi.org/10.3389/fphar.2021.721537 (2021).
doi: 10.3389/fphar.2021.721537
pubmed: 34658861
pmcid: 8517265
Preller, K. H. & Vollenweider, F. X. Modulation of social cognition via hallucinogens and entactogens. Front. Psychiatry. 10, 881. https://doi.org/10.3389/fpsyt.2019.00881 (2019).
doi: 10.3389/fpsyt.2019.00881
pubmed: 31849730
pmcid: 6902301
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F., Bäbler, A., Vogel, H. & Hell, D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport. 9, 3897–3902 (1998).
doi: 10.1097/00001756-199812010-00024
pubmed: 9875725
Halberstadt, A. L. & Geyer, M. A. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. 61, 364–381 (2011).
doi: 10.1016/j.neuropharm.2011.01.017
pubmed: 21256140
pmcid: 3110631
Johnson, M. W. & Griffiths, R. R. Potential therapeutic effects of Psilocybin. Neurotherapeutics. 14(3), 734–740. https://doi.org/10.1007/s13311-017-0542-y (2017).
doi: 10.1007/s13311-017-0542-y
pubmed: 28585222
pmcid: 5509636
Thomas, G., Lucas, P., Capler, N., Tupper, K. & Martin, G. Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Curr. Drug Abuse Rev. 6(1), 30–42. https://doi.org/10.2174/15733998113099990003 (2013).
doi: 10.2174/15733998113099990003
pubmed: 23627784
Oehen, P., Traber, R., Widmer, V. & Schnyder, U. A randomized, controlled pilot study of MDMA (± 3, 4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J. Psychopharmacol. 27(1), 40–52 (2013).
doi: 10.1177/0269881112464827
pubmed: 23118021
Nour, M. M., Evans, L., Nutt, D. & Carhart-Harris, R. L. Ego-dissolution and psychedelics: Validation of the ego-dissolution inventory (EDI). Front. Hum. Neurosci. 10, 269 (2016).
doi: 10.3389/fnhum.2016.00269
pubmed: 27378878
pmcid: 4906025
Yockey, R. A., Vidourek, R. A. & King, K. A. Trends in LSD use among US adults: 2015–2018. Drug Alcohol Depend. 212, 108071. https://doi.org/10.1016/j.drugalcdep.2020.108071 (2020).
doi: 10.1016/j.drugalcdep.2020.108071
pubmed: 32450479
Mason, N. L., Mischler, E., Uthaug, M. V. & Kuypers, K. P. C. Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being. J. Psychoactive Drugs. 51(2), 123–134. https://doi.org/10.1080/02791072.2019.1580804 (2019).
doi: 10.1080/02791072.2019.1580804
pubmed: 30905276
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I. & Vollenweider, F. X. Effect of psilocybin on empathy and moral decision-making. Int. J. Neuropsychopharmacol. 20(9), 747–757. https://doi.org/10.1093/ijnp/pyx047 (2017).
doi: 10.1093/ijnp/pyx047
pubmed: 28637246
pmcid: 5581487
Strassman, R. J. Human psychopharmacology of N,N-dimethyltryptamine. Behav. Brain. Res. 73(1–2), 121–124. https://doi.org/10.1016/0166-4328(96)00081-2 (1995).
doi: 10.1016/0166-4328(96)00081-2
Domínguez-Clavé, E. et al. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Res. Bull. 126, 89–101. https://doi.org/10.1016/j.brainresbull.2016.03.002 (2016).
doi: 10.1016/j.brainresbull.2016.03.002
pubmed: 26976063
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S. & Liechti, M. E. LSD acutely impairs fear recognition and enhances emotional empathy and sociality. Neuropsychopharmacology. 41(11), 2638–2646. https://doi.org/10.1038/npp.2016.82 (2016).
doi: 10.1038/npp.2016.82
pubmed: 27249781
pmcid: 5026740
Dziobek, I. et al. Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). J. Autism Dev. Disord. 38, 464–473 (2008).
doi: 10.1007/s10803-007-0486-x
pubmed: 17990089
Lima, F. F. D. & Osório, F. D. L. Empathy: Assessment instruments and psychometric quality–a systematic literature review with a meta-analysis of the past ten years. Front. Psychol. 12, 781346 (2021).
doi: 10.3389/fpsyg.2021.781346
pubmed: 34899531
pmcid: 8653810
Moher, D. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev.. 4, 1–9 (2015).
doi: 10.1186/2046-4053-4-1
Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36(3), 1–48 (2010).
doi: 10.18637/jss.v036.i03
Borenstein, M. Comprehensive meta-analysis software. Syst. Rev. Health Res. Meta-Anal. Context. 535, 548 (2022).
Cooper, N. J., Sutton, A. J., Morris, D., Ades, A. E. & Welton, N. J. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat. Med. 28(14), 1861–1881. https://doi.org/10.1002/sim.3594 (2009).
doi: 10.1002/sim.3594
pubmed: 19399825
Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 315(7109), 629–634 (1997).
doi: 10.1136/bmj.315.7109.629
pubmed: 9310563
pmcid: 2127453
Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I. & Higgins, J. P. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. bmj, 366.
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M. & Higgins, J. P. (2016). ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. bmj, 355
Aday, J. S., Wood, J. R., Bloesch, E. K. & Davoli, C. C. Psychedelic drugs and perception: A narrative review of the first era of research. Rev. Neurosci. 32(5), 559–571. https://doi.org/10.1515/revneuro-2020-0094 (2021).
doi: 10.1515/revneuro-2020-0094
pubmed: 33550787
Muthukumaraswamy, S. D. et al. Broadband cortical desynchronization underlies the human psychedelic state. J. Neurosci. 33(38), 15171–15183. https://doi.org/10.1523/JNEUROSCI.2063-13.2013 (2013).
doi: 10.1523/JNEUROSCI.2063-13.2013
pubmed: 24048847
pmcid: 6618409
Peled-Avron, L., Levy-Gigi, E., Richter-Levin, G., Korem, N. & Shamay-Tsoory, S. G. The role of empathy in the neural responses to observed human social touch. Cogn. Affect. Behav. Neurosci. 16, 802–813 (2016).
doi: 10.3758/s13415-016-0432-5
pubmed: 27165338
Perry, A., Stein, L. & Bentin, S. Motor and attentional mechanisms involved in social interaction—evidence from mu and alpha EEG suppression. NeuroImage. 58(3), 895–904 (2011).
doi: 10.1016/j.neuroimage.2011.06.060
pubmed: 21742042
Griffiths, R. R. et al. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology. 218(4), 649–665. https://doi.org/10.1007/s00213-011-2358-5 (2011).
doi: 10.1007/s00213-011-2358-5
pubmed: 21674151
pmcid: 3308357
MacLean, K. A., Johnson, M. W. & Griffiths, R. R. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J. Psychopharmacol. 25(11), 1453–1461. https://doi.org/10.1177/0269881111420188 (2011).
doi: 10.1177/0269881111420188
pubmed: 21956378
pmcid: 3537171
Bouso, J. C. et al. Long-term use of psychedelic drugs is Associated with differences in Brain structure and personality in humans. Eur. Neuropsychopharmacol. 25(4), 483–492. https://doi.org/10.1016/j.euroneuro.2015.01.008 (2015).
doi: 10.1016/j.euroneuro.2015.01.008
pubmed: 25637267
Johnstad, P. G. The psychedelic personality: Personality structure and associations in a sample of psychedelics users. J. Psychoact. Drugs. 53(2), 97–103 (2021).
doi: 10.1080/02791072.2020.1842569
pubmed: 33252034
Song, Y. & Shi, M. Associations between empathy and big five personality traits among Chinese undergraduate medical students. PLoS ONE. 12(2), e0171665. https://doi.org/10.1371/journal.pone.0171665 (2017).
doi: 10.1371/journal.pone.0171665
pubmed: 28187194
pmcid: 5302826
Hysek, C. M. et al. MDMA enhances emotional empathy and prosocial behavior. Soc. Cognit. Affect. Neurosci. 9(11), 1645–1652. https://doi.org/10.1093/scan/nst161 (2014).
doi: 10.1093/scan/nst161
Parrott, A. C. Human psychobiology of MDMA or ‘Ecstasy’: An overview of 25 years of empirical research. Hum. Psychopharmacol. Clin. Exp. 28(4), 289–307. https://doi.org/10.1002/hup.2318 (2013).
doi: 10.1002/hup.2318
Holze, F., Avedisian, I., Varghese, N., Eckert, A. & Liechti, M. E. Role of the 5-HT2A receptor in acute effects of LSD on empathy and circulating oxytocin. Front. Pharmacol. 12, 711255. https://doi.org/10.3389/fphar.2021.711255 (2021).
doi: 10.3389/fphar.2021.711255
pubmed: 34326773
pmcid: 8313809
Kroeze, W. K., Sassano, M. F., Huang, X. P., Lansu, K., McCorvy, J. D., Giguère, P. M., & Roth, B. L. (2015). PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22(5), 362–369.
Fan, L., Zhuang, Y., Wu, H., Li, H., Xu, Y., Wang, Y. & Wang, S. (2024). Structural basis of psychedelic LSD recognition at dopamine D1 receptor. Neuron
Nichols, D. E. Psychedelics. Pharmacol. Rev., 68(2), 264–355. (2016).
doi: 10.1124/pr.115.011478
Sarris, J., Perkins, D., Cribb, L., Schubert, V., Opaleye, E., Bouso, J. C., & Tófoli, L. F. (2021). Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers. J. Affect. Disord. Rep., 4, 100098
Brierley, D. I. & Davidson, C. Developments in harmine pharmacology—implications for ayahuasca use and drug-dependence treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry. 39(2), 263–272 (2012).
doi: 10.1016/j.pnpbp.2012.06.001
pubmed: 22691716
Giacomelli, S., Palmery, M., Romanelli, L., Cheng, C. Y. & Silvestrini, B. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro. Life Sci. 63(3), 215–222 (1998).
doi: 10.1016/S0024-3205(98)00262-8
pubmed: 9698051
Baron-Cohen, S., Wheelwright, S., Hill, J., Raste, Y. & Plumb, I. The reading the mind in the eyes test revised version: A study with normal adults, and adults with Asperger syndrome or high-functioning autism. J. Child. Psychol. Psychiatry Allied Disciplines. 42(2), 241–251 (2001).
doi: 10.1111/1469-7610.00715
Dziobek, I. et al. Introducing MASC: A movie for the assessment of social cognition. J. Autism Dev. Disord. 36, 623–636. https://doi.org/10.1007/s10803-006-0107-0 (2006).
doi: 10.1007/s10803-006-0107-0
pubmed: 16755332
Montagne, B., Kessels, R. P., De Haan, E. H. & Perrett, D. I. The emotion recognition task: A paradigm to measure the perception of facial emotional expressions at different intensities. Percept. Mot. Skills. 104(2), 589–598 (2007).
doi: 10.2466/pms.104.2.589-598
pubmed: 17566449
Kometer, R. & Hofbauer, E. Knowing the limits: Surface deviation in the mid-spatial-frequency range by deflectometric measurements. In Eighth European Seminar on Precision Optics Manufacturing (Vol. 11853, 85–95). SPIE. (2021).
Wunderli, M. D., Vonmoos, M., Treichler, L., Zeller, C., Dziobek, I., Kraemer, T., & Quednow, B. B. (2018). Social cognition and interaction in chronic users of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”). Int. J. Neuropsychopharmacol. 21(4), 333-344.
Rocha, J. M., Rossi, G. N., de Lima Osório, F., Bouso, J. C., de Oliveira Silveira, G., Yonamine, M., & Dos Santos, R. G. (2021). Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: A pilot, proof-of-concept, randomized controlled trial. J. Clin. Psychopharmacol. 41(3), 267–274.
Hartogsohn, I. The psycho-social construction of LSD: how set and setting shaped the American psychedelic experience 1950–1970. (2014). Bar Ilan University.
Adamson, S. & Metzner, R. The nature of the MDMA experience and its role in healing, psychotherapy and spiritual practice. ReVision. 10(4), 59–72 (1988).
Tenenbaum, B. Group therapy with LSD-25. (a preliminary report). Dis. Nerv. Syst. 22, 459–462 (1961).
pubmed: 13775877
Arendsen-Hein, G. W. LSD in the Treatment of Criminal Psychopaths. Hallucinogenic Drugs and Their Psychotherapeutic Use 101–106 (HK Lewis & Co. Ltd, 1963).
Leary, T. & Metzner, R. Use of psychedelic drugs in prisoner rehabilitation. Br. J. Soc. Psychiatry, 2(27). (1968).